Navigation Links
Technology reveals 'lock and key' proteins behind diseases

ue. "Like lock and key, if two proteins interact with one another, it is safe to assume they participate or regulate the same cellular process," explains Stagljar. "Identifying new interactors for ABC transporters may reveal unanticipated aspects of how these transporters function and help researchers gain clues for fighting disease and drug resistance."

Using iMYTH, the Stagljar lab identified six proteins that interact with and presumably communicate with the ABC transporter Ycf1p, a yeast version of the human proteins CFTR and MRP. These newly discovered protein interactors represent novel potential pharmaceutical targets. Through a series of biochemical and genetic tests, the researchers discovered that one of these interactors, Tus1p, regulates Ycf1p transporter function in a completely novel way to stimulate its ability to remove toxins from the cell.

"The more we learn about membrane proteins, the better we can use this knowledge for pharmacological and clinical applications," Stagljar says. "We work by putting together biochemical processes piece by piece like a puzzle. Hopefully soon we will have a complete picture of how many other diseases such as breast cancer, heart diseases, arthritis and schizophrenia are caused by mutations in various human membrane proteins."
'"/>

Source:University of Toronto


Page: 1 2

Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
3. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
4. Technology for monitoring fetal oxygen during labor offers no apparent benefit
5. Technology exists to keep E. coli out of food
6. A bacterial genome reveals new targets to combat infectious disease
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Examination of internal wiring of yeast, worm, and fly reveals conserved circuits
9. NYU study reveals how brains immune system fights viral encephalitis
10. Study reveals new technique for fingerprinting environmental samples
11. Study reveals dramatic difference between breast cancers in US and Africa
Post Your Comments:
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2New therapy targets for amyloid disease 2A window that washes itself? 2Genomic Health to Present at Piper Jaffray Health Care Conference 14955 1Genomic Health to Present at Piper Jaffray Health Care Conference 14955 2Visage Imaging Introduces Visage 28R 29 7 for Windows and Mac OS X 6500 1Visage Imaging Introduces Visage 28R 29 7 for Windows and Mac OS X 6500 2Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6495 1Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6495 2
...t trimester of pregnancy is clearly linked with an...at play a role in detoxification of cigarette smok... new study published in the journal Epidemiology ... defects. Closure of the lip occurs about 5 weeks ...at week 9. If this does not happen, a cleft lip an...
...gemeinschaft (DFG, German Research Foundation) has...y innovative and higher-risk research. They are th...e DFG,s Reinhart Koselleck Projects programme. The...euros and 1.25 million euros for their planned res...y over a five-year period. , The DFG,s Reinhart ...
...gical tit for tat may hold clues to improving the ... type 1 diabetes, according to a Medical College o...em attacks insulin-producing cells causing high bl... attack, said Dr. Rafal Pacholczyk, an immunologis...Medicine. , He just received a three-year, $495,0...
Other Biology News:First trimester smoking linked to oral clefts 2More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 2More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 3More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 4High blood sugar's impact on immune system holds clues to improving islet cell transplants 2High blood sugar's impact on immune system holds clues to improving islet cell transplants 3
(Date:12/4/2009)Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts, health & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaini
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4
...dium Therapeutics,(Amex: CXM ) announced positive...ed by researchers at Emory University, which demon...rs within acutely ischemic myocardium,(heart muscl...ckage of the,coronary arteries). The study employe...a heart attack or acute myocardial infarction, in ...
...ch 11 Pressure,BioSciences, Inc. (Nasdaq: PBIO )...s joined PBI,s senior executive management team as...im nearly twenty years of experience in,sales and ...ces companies.,Mr. Potter will oversee PBI,s seven...sponsible for driving the Company,s commercializat...
...11 Schering-Plough,Corporation (NYSE: SGP ) toda... Administration (FDA) of a New Drug Application (N... in the dosage strength of 20 mg of,omeprazole as ...frequent,heartburn., The NDA was submitted under ...c. of San Diego, Calif., which was signed in Octob...
Other Biology Technology:Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 2Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 3Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 4Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 5Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 6Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion 7Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 2Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 3Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales 4Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R) 2Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R) 3
FIA-series XYZ autosampler from Ocean Optics
Mouse Matrilin-4 from R&D Systems
EDTA Solution (pH 8.0) (0.5 M) from BioVision
...eals labware. Waterproof, moisture-proof film prev...nhydrous materials. Can be folded repeatedly and t...etched lengthwise at 21C (70F), wrapping film incr...ved, film only partially returns to original lengt...
Biology Products: